Short interest in Intra-Cellular Therapies Inc (NASDAQ:ITCI) increased during the last reporting period, rising from 1.50M to 1.60M. This put 1.73% of the company's publicly available shares short.

Short interest for Intra-Cellular Therapies gives investors a sense of the degree to which investors are betting on the decline of Intra-Cellular Therapies's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 4.16M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.